Carline Vanden Abeele
GlaxoSmithKline (Belgium)(BE)
Publications by Year
Research Areas
Respiratory viral infections research, Herpesvirus Infections and Treatments, Protein Kinase Regulation and GTPase Signaling, Pneumonia and Respiratory Infections, Poxvirus research and outbreaks
Most-Cited Works
- → Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older(2016)1,017 cited
- → Once-daily darunavir/ritonavir vs. lopinavir/ritonavir in treatment-naive, HIV-1-infected patients: 96-week analysis(2009)266 cited
- → Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older(2018)192 cited
- → Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial(2022)113 cited
- → Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study(2017)50 cited
- → The RSVPreF3-AS01 vaccine elicits broad neutralization of contemporary and antigenically distant respiratory syncytial virus strains(2023)29 cited
- → Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1–2 randomised controlled trial(2022)29 cited
- → Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)(2016)26 cited
- → Diffusion of Glucose in Carrageenan Gels(1986)24 cited
- → Safety and Immunogenicity of a Revaccination With a Respiratory Syncytial Virus Prefusion F Vaccine in Older Adults: A Phase 2b Study(2023)21 cited